Novo Nordisk debuts Wegovy weight-loss pill in the U.S.

FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.

  Health   Jan 6, 2026   0   20  Add to Reading List
Novo Nordisk debuts Wegovy weight-loss pill in the U.S.
FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.
Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow